6-(4-tert-butylnaphthalen-2-yl)-4-[2-[4-(2,2-dimethylpropyl)phenyl]-1,3-thiazol-5-yl]pyridine-3-carbonitrile
C34H33N3S — CID 164796395
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(4-tert-butylnaphthalen-2-yl)-4-[2-[4-(2,2-dimethylpropyl)phenyl]-1,3-thiazol-5-yl]pyridine-3-carbonitrile
6-(4-tert-butylnaphthalen-2-yl)-4-[2-[4-(2,2-dimethylpropyl)phenyl]-1,3-thiazol-5-yl]pyridine-3-carbonitrile (PubChem CID 164796395) has the molecular formula C34H33N3S and a molecular weight of 515.73 g/mol. Its IUPAC name is 6-(4-tert-butylnaphthalen-2-yl)-4-[2-[4-(2,2-dimethylpropyl)phenyl]-1,3-thiazol-5-yl]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 6-(4-tert-butylnaphthalen-2-yl)-4-[2-[4-(2,2-dimethylpropyl)phenyl]-1,3-thiazol-5-yl]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 164796395 |
| Molecular Formula | C34H33N3S |
| Molecular Weight | 515.73 g/mol |
| Exact Mass | 515.24 |
| IUPAC Name | 6-(4-tert-butylnaphthalen-2-yl)-4-[2-[4-(2,2-dimethylpropyl)phenyl]-1,3-thiazol-5-yl]pyridine-3-carbonitrile |
| SMILES | CC(C)(C)Cc1ccc(-c2ncc(-c3cc(-c4cc(C(C)(C)C)c5ccccc5c4)ncc3C#N)s2)cc1 |
| InChI | InChI=1S/C34H33N3S/c1-33(2,3)18-22-11-13-23(14-12-22)32-37-21-31(38-32)28-17-30(36-20-26(28)19-35)25-15-24-9-7-8-10-27(24)29(16-25)34(4,5)6/h7-17,20-21H,18H2,1-6H3 |
| InChIKey | JVBCHROGJCJNCY-UHFFFAOYSA-N |
| XLogP | 9.45 |
| TPSA | 49.57 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 515.73 |
| LogP ≤ 5 | 9.45 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164796395 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.